Mental health problems are common in Huntington’s disease, but there isn’t much data on patients’ use of psychiatric…
Articles by Marisa Wexler, MS
LETI-101, an experimental gene-editing therapy for Huntington’s disease, showed promising proof-of-concept effects in mouse and cell models by reducing levels…
Specific genes involved in repairing mismatched DNA contribute to the development of Huntington’s disease by driving fast somatic CAG…
In specific brain cells, the mutation that causes Huntington’s disease grows more and more unstable as years go by,…
Abnormalities in a protein called TDP-43, which is known to play a key role in the development of amyotrophic…
Throughout 2024, the team at Huntington’s Disease News covered the latest developments in research and news related to…
The U.S. Food and Drug Administration (FDA) has agreed that results from two ongoing Phase 1/2 clinical trials, compared with…
Beta-blockers, a class of medicines often used to manage heart and blood pressure issues, may slow the onset and progression…
Ingrezza (valbenazine), an approved treatment for chorea, or uncontrolled movements, related to Huntington’s disease, shows similar effectiveness…
Being physically active is significantly associated with a delayed age of the onset of Huntington’s disease and spending more…